Navin Fluorine Shares Hit Record High, Surge 11% After Strong Q1 FY 2026-27 Earnings
Add Preferred News Source
Navin Fluorine shares surged 11% to touch a record high of Rs 8,422 after strong Q1 FY 2026-27 earnings, with net profit more than doubling year-on-year.
Shares of Navin Fluorine International Ltd were trading at Rs 8,422, up Rs 812.50 or 10.68 percent, as of 12:19 pm IST on Thursday, August 6, after touching a record high earlier in the session. This marks the stock's biggest single-day gain since October 2025, a day after the speciality chemicals maker reported a strong set of June-quarter earnings. The stock is now up 42 percent so far this year.
The rally comes after Navin Fluorine reported a 107.6 percent year-on-year jump in consolidated net profit to Rs 243.3 crore for the quarter ended June, compared with Rs 117.2 crore a year ago. Revenue from operations rose 44.1 percent to Rs 1,045.1 crore, while EBITDA climbed 72.7 percent to Rs 357 crore. EBITDA margin expanded sharply to 34.2 percent from 28.5 percent a year earlier, aided by stronger volumes, better realisations and operating leverage across businesses.
According to a research note from Kotak Neo Research, the quarter came in better than expected, led entirely by another sharp jump in revenue from the High Performance Products business, chiefly comprising R-32, amid higher prices and volumes. Adjusted EPS grew 20 percent sequentially and 101 percent year-on-year to Rs 47.5. The report switched to a sum-of-the-parts valuation methodology for greater granularity on value drivers and arrived at a revised fair value of Rs 5,250, up from Rs 4,990 earlier, while retaining a SELL rating.
The research note flagged that CDMO revenues declined 3.2 percent sequentially and Speciality Chemicals revenues fell 9.7 percent sequentially, with gross margins correcting 165 basis points quarter-on-quarter. It also pointed out that the R-32 business is a declining annuity with an 85 percent phase-down in volumes expected by 2047, and flagged likely pressure on growth and margins of the Nubeqa business after patent expiry in the mid-2030s.
The board also approved a capital expenditure of Rs 90 crore to establish adoption capacities at its Surat facility for its Advanced Materials portfolio, aimed at scaling laboratory-stage products to commercial qualification and strengthening the company's presence in specialised fluorochemical applications.
Also Read - Navin Fluorine Q1 FY 2026-27 Results: Net Profit Doubles To ₹243 Crore, Revenue Climbs 44%
This article is for informational purposes only and should not be considered investment advice from Kotak Neo. For compliance T&C and disclaimers, visit www.kotakneo.com/disclaimer.
Rochelle Britto is a business journalist with 8+ years of experience in financial journalism. She covers equity markets, corporate earnings, IPOs, commodities and the economy.
As a reporter with leading business publications, she has tracked financial markets and covered sectors including banking and financial services, retail, consumer goods, advertising and e-commerce.
Outside work, she enjoys travelling, discovering local cultures and spending time in nature.
0 people liked this article.
